Search - tctmd.com

Displaying 721 - 740 of 5772

Sort: Relevancy | Date

News Daily News

FDA Approves Paradise Renal Denervation System: What Comes Next?

Todd Neale

November 08, 2023

News Conference News AHA 2023

Off-label DOAC Dosing Common in Hospitalized AF Patients, Too

Todd Neale

November 07, 2023

News Conference News VIVA 2023

‘Dire’ Lack of Vascular Care in Underserved Areas Needs Creativity, Compassion

L.A. McKeown

November 03, 2023

News Conference News TCT 2023

Post-TAVI Conduction Abnormalities: EP Study, Registry Data Provide Snapshots

Caitlin E. Cox

November 03, 2023

News Conference News TCT 2023

MitraClip G4 Data Impress, but Some Question the Reproducibility: EXPAND G4

Yael L. Maxwell

November 02, 2023

News Opinion CV Team Dispatch

November 2023 News Roundup

L.A. McKeown

November 01, 2023

News Conference News TCT 2023

SUMMIT: MV Replacement With Tendyne Shows Promise in Severe MR, MAC

Yael L. Maxwell

October 30, 2023

News Conference News TCT 2023

BIOSTEMI: Degradable-Polymer, Ultrathin-Strut DES Shows No Late Catch-up at 5 Years

Caitlin E. Cox

October 27, 2023

News Conference News TCT 2023

TRILUMINATE Deep Dive Clarifies ‘Meaningful’ QoL Gains With Tricuspid TEER

Yael L. Maxwell

October 26, 2023

News Conference News TCT 2023

No Mortality Signal for iFR in Real-world Use: SWEDEHEART

Caitlin E. Cox

October 26, 2023

News Conference News TCT 2023

Does Thrombolysis Have a Role in a Primary-PCI World? Experts Hash It Out

Michael O'Riordan

October 25, 2023

Presentation TCT 2023

TCT 759: Comparative Efficacy and Safety of Transcatheter Edge-to-edge Mitral Valve Repair Versus Medical Therapy for Mitral Regurgitation: A Systematic Review and Meta-Analysis

Presenter: Shroukm Ramadan

October 25, 2023

News Conference News TCT 2023

In ACS, Ticagrelor Only After < 1 Month DAPT Beats Continuing Aspirin: T-PASS

Yael L. Maxwell

October 25, 2023

News Conference News TCT 2023

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

L.A. McKeown

October 25, 2023

News Conference News TCT 2023

Comparing DCBs in De Novo CAD: Drugs, Design Matter

Caitlin E. Cox

October 25, 2023

News Conference News TCT 2023

‘Light at the End of the Tunnel’ for In-Stent Restenosis: AGENT IDE Wins Big

Todd Neale

October 25, 2023

News Conference News TCT 2023

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

L.A. McKeown

October 24, 2023

News Conference News TCT 2023

More TRILUMINATE Patients Flesh Out Tricuspid TEER’s Impact

Yael L. Maxwell

October 24, 2023

News Conference News TCT 2023

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

Michael O'Riordan

October 24, 2023

Presentation TCT 2023

TCT 323: Inverse Relationship Between Age and Coronary Events In Medically Treated Lesion After Fractional Flow Reserve Measurement

Presenter: So-Min Lim

October 24, 2023

Advertisement

FDA Approves Paradise Renal Denervation System: What Comes Next?

Off-label DOAC Dosing Common in Hospitalized AF Patients, Too

‘Dire’ Lack of Vascular Care in Underserved Areas Needs Creativity, Compassion

Post-TAVI Conduction Abnormalities: EP Study, Registry Data Provide Snapshots

MitraClip G4 Data Impress, but Some Question the Reproducibility: EXPAND G4

November 2023 News Roundup

SUMMIT: MV Replacement With Tendyne Shows Promise in Severe MR, MAC

BIOSTEMI: Degradable-Polymer, Ultrathin-Strut DES Shows No Late Catch-up at 5 Years

TRILUMINATE Deep Dive Clarifies ‘Meaningful’ QoL Gains With Tricuspid TEER

No Mortality Signal for iFR in Real-world Use: SWEDEHEART

Does Thrombolysis Have a Role in a Primary-PCI World? Experts Hash It Out

TCT 759: Comparative Efficacy and Safety of Transcatheter Edge-to-edge Mitral Valve Repair Versus Medical Therapy for Mitral Regurgitation: A Systematic Review and Meta-Analysis

In ACS, Ticagrelor Only After < 1 Month DAPT Beats Continuing Aspirin: T-PASS

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

Comparing DCBs in De Novo CAD: Drugs, Design Matter

‘Light at the End of the Tunnel’ for In-Stent Restenosis: AGENT IDE Wins Big

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

More TRILUMINATE Patients Flesh Out Tricuspid TEER’s Impact

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

TCT 323: Inverse Relationship Between Age and Coronary Events In Medically Treated Lesion After Fractional Flow Reserve Measurement

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content